Tilray Jumps on Study of Cannabis for Breast Cancer Side Effects

(Bloomberg) -- Tilray Inc. shares jumped as much as 14% after announcing it successfully imported medical cannabis into the U.S. in support of a clinical trial studying its efficacy in treating pat...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.